October 2017 Eppendorf India announces the extension of the training centre at its facility in Ambattur. Eppendorf India, a wholly owned subsidiary of Eppendorf AG, today announces the extension of the training centre at its facility in Ambattur, Chennai. Eppendorf is committed to skill development and this measure further enhances the possibility of offering tailor... Read more
RADNOR, Pa., Oct. 17, 2017 /PRNewswire/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, today announced its collaborating with Scientist.com, the leading global online marketplace for research services. VWR customers in the U.S. can now purchase thousands of custom products and research services through... Read more
Basel, 06 October 2017 FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus Zika virus infection is linked to neurological complications in adults, and brain defects in fetuses and newborn infants cobas Zika complements efforts to prevent the spread of Zika virus through blood donations in the U.S. cobas Zika... Read more
Basel, 06 October 2017 FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus Zika virus infection is linked to neurological complications in adults, and brain defects in fetuses and newborn infants cobas Zika complements efforts to prevent the spread of Zika virus through blood donations in the U.S. cobas Zika... Read more
Mining and Soil Modes Added to Smallest and Lightest Handheld XRF Elemental Analyzer Thermo Scientific Niton XL5 handheld XRF analyzer now offers additional functionality and new accessories, including collapsible mini test stand TEWKSBURY, Mass., Oct. 2, 2017 /PRNewswire/ — Geologists, mining companies and environmental laboratories can now generate x-ray fluorescence (XRF) analysis faster in the... Read more
Basel, 29 September 2017 FDA grants Priority Review for Roche’s Perjeta (pertuzumab) for adjuvant treatment of HER2-positive early breast cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Perjeta® (pertuzumab), in combination with Herceptin®... Read more
Basel, 29 September 2017 FDA grants Priority Review for Roche’s Perjeta (pertuzumab) for adjuvant treatment of HER2-positive early breast cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Perjeta® (pertuzumab), in combination with Herceptin®... Read more
Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx SANTA CLARA, Calif., September 22, 2017 Agilent Technologies Inc. (NYSE: A) today announced its Dako PD-L1 IHC 22C3 pharmDx assay has an expanded label approved by U.S. Food and Drug... Read more
New Facility Helps Scientists Advance Translational Medical Research WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the opening of the Translational Medical Engineering Demonstration Laboratory at a ceremony on September 19. Co-founded with the State Key Laboratory of Biochemical Engineering, this facility will serve as a center for... Read more
Thermo Fisher Scientific Laboratory Freezers Earn U.S. EPA ENERGY STAR Rating WALTHAM, Mass., Sept. 18, 2017 /PRNewswire/ — Laboratories can now rely on Thermo Fisher Scientific’s expanded line of cold-storage products to help them meet their goals for both productivity and sustainability. The company recently earned the U.S. Environmental Protection Agency’s (EPA’s) ENERGY STAR certification... Read more